Proposal for an updated seizure classification framework in clinical trials

Area of Science:

• Neurology
• Epileptology
• Clinical Trials

Background:

• The International League Against Epilepsy (ILAE) seizure classification is periodically updated.
• Current classification has limitations in clinical trial applicability and reliability.
• Need for a standardized, pragmatic approach in epilepsy research.

Purpose of the Study:

• To propose a pragmatic seizure classification for clinical trials.
• To enhance reliability and interpretability of outcome measures.
• To support the development of novel antiseizure medications.

Main Methods:

• Adaptation of the existing ILAE seizure classification.
• Focus on outcome measures with high reliability and clinical relevance.
• Discussion of controversies and simplifications for clinical trial use.

Main Results:

• A proposed pragmatic seizure classification based on the ILAE scheme.
• Identification of key outcome measures for clinical trials.
• Addressing controversies in seizure classification for drug development.

Conclusions:

• The proposed pragmatic classification can improve clinical trial design.
• Enhanced seizure classification aids in developing effective antiseizure medications.
• This approach benefits investigators, sponsors, and regulatory agencies.